CD68 and neoplasm: Multiplex immunohistochemistry assay was performed in seven patients (P01-P06 and P09) to simultaneously measure the expression of the multiple surface markers associated with the tumor microenvironment, such as PD-1, PD-L1, CD3, CD8, CD68, CD56 and CD163 (Table 3).